Akoya Biosciences Inc has a consensus price target of $7.93 based on the ratings of 10 analysts. The high is $19 issued by Capital One on November 3, 2022. The low is $3 issued by Morgan Stanley on August 6, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, Morgan Stanley, and Craig-Hallum on August 13, 2024, August 6, 2024, and August 6, 2024, respectively. With an average price target of $4.67 between Piper Sandler, Morgan Stanley, and Craig-Hallum, there's an implied 60.37% upside for Akoya Biosciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Akoya Biosciences (NASDAQ:AKYA) was reported by Piper Sandler on August 13, 2024. The analyst firm set a price target for $4.00 expecting AKYA to rise to within 12 months (a possible 37.46% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Akoya Biosciences (NASDAQ:AKYA) was provided by Piper Sandler, and Akoya Biosciences maintained their overweight rating.
There is no last upgrade for Akoya Biosciences
The last downgrade for Akoya Biosciences Inc happened on August 6, 2024 when Morgan Stanley changed their price target from $4 to $3 for Akoya Biosciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Akoya Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Akoya Biosciences was filed on August 13, 2024 so you should expect the next rating to be made available sometime around August 13, 2025.
While ratings are subjective and will change, the latest Akoya Biosciences (AKYA) rating was a maintained with a price target of $6.00 to $4.00. The current price Akoya Biosciences (AKYA) is trading at is $2.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.